Showing all 11 results
-
Lutathera
Lutathera (lutetium (177Lu) oxodotreotide) is a cancer medicine for treating tumours in the gut known as gastroenteropancreatic neuroendocrine tumours (GEP‑NETs). It is a radiopharmaceutical (a medicine that emits a small amount of radioactivity). Lutathera is used to treat GEP-NETs that cannot be removed by surgery, have spread to other parts of the body or are not responding to treatment. Lutathera was designated an 'orphan medicine' (a medicine used in rare diseases) on 31 January 2008. If you are a SAM Nordic customer and wish to order Lutathera, please download the order form, complete it and send to order@samnordic.se Download Lutathera Order Form hereRead more -
GalliAd
500 SEK – 600 SEKGalliAd is the first Gallium Generator specifically designed for preparation of cold kits. It is approved for our PET-kit SomaKit TOC.Read more -
SomaKit TOC
SomaKit TOC is used to diagnos patients with GEP-NET, to find out whether the tumor overexpresses somatostatinreceptors or not, and to localizing primary tumours and their metastases. The kit is the first ever approved PET radiopharmaceutical kit. The 68Ga-generators approved to use for reconstitution are GalliAd and GalliaPharm. The national guidelines for GEP-NET in Sweden recommends that a Gallium-Dotatoc-PET shoud be performed when diagnosing GEP-NET's.Read more -
FDG (Fludeoxyglucose [18F])
This medicinal product is for diagnostic use only. Fludeoxyglucose (18F) is intended for use with positron emission tomography (PET) for adults and children.Read more -
Sammibi
Sammibi is a 99mTc-kit normally used for diagnosis of ischaemic heart disease and hyperparathyroidism. It is easily reconstituted with a long shelf life.Read more -
Tektrotyd
Tektrotyd is a SPECT/CT alternative for diagnosing GEP-NET tumours that overexpresses somatostatinreceptors. It is a kit for the radiopharmaceutical preparation of 99mTc.Read more -
Poltechnet
Poltechnet 8.0-175 GBq is a radionuclide generator. To order this product, please contact Customer Service.Read more -
-
-
-
